The investigational study drug is called VGX-3100. It is delivered with a medical device that is designed to increase the amount of study drug or placebo taken up by the muscle. Doctors hope that VGX-3100 delivered by the medical device will boost your body’s immune response to human papillomavirus (HPV) infection and clear the precancerous cells of the cervix.
VGX-3100 may boost your immune system.
These new proteins may become “targets” for the body’s immune system. These targets may help the immune system find and treat the precancerous cells of the cervix.
The placebo is given in the same way as the investigational study drug. There is a 1 in 3 chance you will be in the placebo group. If you are in the placebo group, you may not receive any benefits from this study.